ARDELYX, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
ARDELYX, INC. (ARDX) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 45.62 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-06
- ARDELYX, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 45.62M shares, a 2.73% increase year-over-year.
- ARDELYX, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 45.32M shares, a 14.12% increase year-over-year.
- ARDELYX, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 43.76M shares, a 18.98% increase year-over-year.
- ARDELYX, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 44.41M shares, a 23.50% increase year-over-year.
- ARDELYX, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 42.77M shares, a 19.10% increase from fiscal 2024.
- ARDELYX, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 35.91M shares, a 48.33% increase from fiscal 2023.
- ARDELYX, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 24.21M shares, a 47.80% increase from fiscal 2022.
- ARDELYX, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 16.38M shares, a 19.75% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 45.62M shares 10-Q · filed 2026-08-06 | 45.47M shares 10-Q · filed 2026-08-06 | ||||||
| 2026-03-31 | 45.32M shares 10-Q · filed 2026-04-30 | |||||||
| 2025-12-31 | 42.77M shares 10-K · filed 2026-02-19 | |||||||
| 2025-09-30 | 43.76M shares 10-Q · filed 2025-10-30 | 42.62M shares 10-Q · filed 2025-10-30 | ||||||
| 2025-06-30 | 44.41M shares 10-Q · filed 2026-08-06 | 42.07M shares 10-Q · filed 2026-08-06 | ||||||
| 2025-03-31 | 39.71M shares 10-Q · filed 2026-04-30 | |||||||
| 2024-12-31 | 35.91M shares 10-K · filed 2026-02-19 | |||||||
| 2024-09-30 | 36.78M shares 10-Q · filed 2025-10-30 | 35.57M shares 10-Q · filed 2025-10-30 | ||||||
| 2024-06-30 | 35.96M shares 10-Q · filed 2025-08-04 | 34.94M shares 10-Q · filed 2025-08-04 | ||||||
| 2024-03-31 | 33.93M shares 10-Q · filed 2025-05-01 | |||||||
| 2023-12-31 | 24.21M shares 10-K · filed 2026-02-19 | |||||||
| 2023-09-30 | 15.18M shares 10-Q · filed 2024-10-31 | 23.79M shares 10-Q · filed 2024-10-31 | ||||||
| 2023-06-30 | 23.95M shares 10-Q · filed 2024-08-01 | 23.47M shares 10-Q · filed 2024-08-01 | ||||||
| 2023-03-31 | 22.99M shares 10-Q · filed 2024-05-02 | |||||||
| 2022-12-31 | 16.38M shares 10-K · filed 2025-02-20 | |||||||
| 2022-09-30 | 15.60M shares 10-Q · filed 2023-10-31 | 16.72M shares 10-Q · filed 2023-10-31 | ||||||
| 2022-06-30 | 16.82M shares 10-Q · filed 2023-08-02 | 17.32M shares 10-Q · filed 2023-08-02 | ||||||
| 2022-03-31 | 17.83M shares 10-Q · filed 2023-05-03 | 13.30M shares 10-Q · filed 2022-05-05 | ||||||
| 2021-12-31 | 13.68M shares 10-K · filed 2024-02-22 | 13.68M shares 10-K · filed 2022-02-28 | ||||||
| 2021-09-30 | 13.22M shares 10-Q · filed 2022-11-03 | 13.20M shares 10-Q · filed 2021-11-12 | 13.37M shares 10-Q · filed 2022-11-03 | 13.40M shares 10-Q · filed 2021-11-12 | ||||
| 2021-06-30 | 13.80M shares 10-Q · filed 2022-08-04 | 13.80M shares 10-Q · filed 2021-08-13 | 13.41M shares 10-Q · filed 2022-08-04 | 13.40M shares 10-Q · filed 2021-08-13 | ||||
| 2021-03-31 | 13.00M shares 10-Q · filed 2022-05-05 | |||||||
| 2020-12-31 | 10.30M shares 10-K · filed 2023-03-02 | 10.30M shares 10-K · filed 2021-03-08 | ||||||
| 2020-09-30 | 9.60M shares 10-Q · filed 2021-11-12 | 10.40M shares 10-Q · filed 2021-11-12 | ||||||
| 2020-06-30 | 11.50M shares 10-Q · filed 2021-08-13 | 11.70M shares 10-Q · filed 2021-08-13 | ||||||
| 2020-03-31 | 11.90M shares 10-Q · filed 2021-05-06 | |||||||
| 2019-12-31 | 10.25M shares 10-K · filed 2022-02-28 | |||||||
| 2019-09-30 | 10.50M shares 10-Q · filed 2020-11-05 | 10.20M shares 10-Q · filed 2020-11-05 | ||||||
| 2019-06-30 | 10.20M shares 10-Q · filed 2019-08-09 | 10.00M shares 10-Q · filed 2019-08-09 | ||||||
| 2019-03-31 | 9.90M shares 10-Q · filed 2019-05-07 | |||||||
| 2018-12-31 | 8.21M shares 10-K · filed 2021-03-08 | |||||||
| 2018-09-30 | 8.30M shares 10-Q · filed 2019-11-06 | 8.10M shares 10-Q · filed 2019-11-06 | ||||||
| 2018-06-30 | 7.90M shares 10-Q · filed 2019-08-09 | 8.00M shares 10-Q · filed 2019-08-09 | ||||||
| 2018-03-31 | 8.00M shares 10-Q · filed 2019-05-07 | |||||||
| 2017-12-31 | 6.68M shares 10-K · filed 2020-03-06 | |||||||
| 2017-09-30 | 7.00M shares 10-Q · filed 2018-11-07 | 6.60M shares 10-Q · filed 2018-11-07 | ||||||
| 2017-06-30 | 6.60M shares 10-Q · filed 2018-08-07 | 6.40M shares 10-Q · filed 2018-08-07 | ||||||
| 2017-03-31 | 6.10M shares 10-Q · filed 2018-05-08 | |||||||
| 2016-12-31 | 4.76M shares 10-K · filed 2019-03-06 | 4.73M shares 10-K · filed 2017-02-17 | ||||||
| 2016-09-30 | 4.70M shares 10-Q · filed 2017-11-07 | 4.60M shares 10-Q · filed 2017-11-07 | ||||||
| 2016-06-30 | 4.70M shares 10-Q · filed 2017-08-09 | 4.60M shares 10-Q · filed 2017-08-09 | ||||||
| 2016-03-31 | 4.50M shares 10-Q · filed 2017-05-05 | |||||||
| 2015-12-31 | 2.53M shares 10-K · filed 2018-03-14 | 1.54M shares 10-K · filed 2016-03-04 | ||||||
| 2015-09-30 | 1.80M shares 10-Q · filed 2016-11-07 | 1.40M shares 10-Q · filed 2016-11-07 | ||||||
| 2015-06-30 | 500.00K shares 10-Q · filed 2016-08-08 | 400.00K shares 10-Q · filed 2016-08-08 | ||||||
| 2015-03-31 | 1.20M shares 10-Q · filed 2016-05-09 | |||||||
| 2014-12-31 | 1.01M shares 10-K · filed 2017-02-17 | |||||||
| 2014-09-30 | 100.00K shares 10-Q · filed 2015-11-12 | 63.89K shares 10-Q · filed 2014-11-07 | 1.10M shares 10-Q · filed 2015-11-12 | 1.07M shares 10-Q · filed 2014-11-07 | ||||
| 2014-06-30 | 12.46K shares 10-Q · filed 2014-08-08 | 1.10M shares 10-Q · filed 2015-08-12 | 1.13M shares 10-Q · filed 2014-08-08 | |||||
| 2014-03-31 | 1.10M shares 10-Q · filed 2015-05-12 | |||||||
| 2013-12-31 | 13.26M shares 10-K · filed 2016-03-04 | |||||||
| 2013-09-30 | 13.30M shares 10-Q · filed 2014-11-07 | 13.30M shares 10-Q · filed 2014-11-07 | ||||||
| 2013-06-30 | 13.31M shares 10-Q · filed 2014-08-08 | 13.31M shares 10-Q · filed 2014-08-08 | ||||||
| 2012-12-31 | 13.39M shares 10-K · filed 2015-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |